Heart Rate Variability clinical trials

Explore recruiting heart rate variability clinical trials.

Recruiting heart rate variability studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Heart Rate Variability trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy of Dexmedetomidine on Emergence Delirium in Children Undergoing Adenotonsillectomy: A Double-Blind Randomized Controlled Trial with Heart Rate Variability and Electroencephalography-Guided Anesthesia

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, triple-blind, placebo-controlled study on the effect of rifaximin on psychobiological functions in healthy men.

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Evaluation of the effectiveness of the reconsolidation therapy in a clinical population suffering from post-traumatic stress disorder

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Evaluation of oxytocin treatment in children with autism and intellectual disability’, Multiple-dose Oxytocine - ASD and Intellectual Disability

Belgium

Phase III and phase IV (Integrated) EU CTIS Study details

A randomized, placebo-controlled, double-blind, 3-period cross-over study in youth with autism spectrum disorders evaluating neural plasticity and learning after a single administration of intranasal oxytocin

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, placebo-controlled, double-blind, 2-period cross-over study in youth with autism spectrum disorders evaluating social and repetitive behaviors after four weeks of twice daily-doses of 24IU of intranasally administered oxytocin

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Heart Rate Variability trials by city

Heart Rate Variability in Toronto Heart Rate Variability in Vancouver Heart Rate Variability in Montreal Heart Rate Variability in Calgary Heart Rate Variability in Edmonton Heart Rate Variability in Ottawa Heart Rate Variability in Winnipeg Heart Rate Variability in Quebec City Heart Rate Variability in Hamilton Heart Rate Variability in Kitchener Heart Rate Variability in London Heart Rate Variability in Halifax Heart Rate Variability in New York Heart Rate Variability in Los Angeles Heart Rate Variability in Chicago Heart Rate Variability in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease